Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
NTLA
Stock Latest News
The Fly
Intellia Therapeutics announces FDA RMAT designation to nex-z
2d ago
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment buys 205K shares of Intellia Therapeutics today
15d ago
NTLA
Premium
Weekend Updates
Palantir, Barrick, Intuit, Intellia, Beyond: Trending by Analysts
20d ago
BYON
GOLD
Premium
The Fly
Royal Caribbean upgraded, AppLovin downgraded: Wall Street’s top analyst calls
23d ago
APP
GEV
Premium
The Fly
Intellia Therapeutics initiated with a Buy at H.C. Wainwright
23d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $50 from $90 at Truist
24d ago
NTLA
Premium
Ratings
Intellia Therapeutics: Promising Potential in Biotech with NTLA-2002 Advancements and Strategic Focus
25d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $50 from $90 at Truist
25d ago
NTLA
Premium
Ratings
Positive Outlook on Intellia Therapeutics: Buy Rating Supported by Financial Performance and Sector Alignment
26d ago
NTLA
Premium
Ratings
Intellia Therapeutics’ Promising Future: Buy Rating Backed by Strong Financials and Program Advancements
27d ago
NTLA
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
28d ago
NKE
PDD
Premium
The Fly
Intellia Therapeutics price target lowered to $37 from $47 at RBC Capital
28d ago
NTLA
Premium
Ratings
Intellia Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
28d ago
NTLA
Premium
The Fly
Goldman downgrades Intellia to Sell on challenging commercial outlook
28d ago
NTLA
Premium
The Fly
Intellia Therapeutics downgraded to Sell from Neutral at Goldman Sachs
28d ago
NTLA
Premium
Ratings
Intellia Therapeutics: Strong Cash Position and Strategic Cost Reductions Drive Buy Rating and Increased Price Target
28d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target raised to $14 from $12 at Citi
28d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $50 from $60 at Wells Fargo
28d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $26 from $55 at Barclays
28d ago
NTLA
Premium
Ratings
Intellia Therapeutics: Hold Rating Amid Long-Term Prospects and Strategic Restructuring
29d ago
NTLA
Premium
Company Announcements
Intellia Therapeutics Reports 2024 Financial Results and Progress
29d ago
NTLA
Premium
Company Announcements
Intellia Therapeutics’ Earnings Call: Progress and Challenges
29d ago
NTLA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
